Ascent Group’s Chemed CHE Stock Holding History

Ascent Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-341	Closed	-$210K	–	725
2025 Q1	$210K	Sell	341 -146	-30%	-$83K	0.01%	652
2024 Q4	$258K	Buy	+487	New	+$275K	0.02%	474

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ascent Group's CHE Position: Q2 2025 in Review

Ascent Group sold out of Chemed (CHE) in Q2 2025, closing a stake of 341 shares — an estimated $210K sold.

Ascent Group first reported a position in CHE in Q4 2024 and held it in 2 quarters. The position peaked at $258K in Q4 2024. 537 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

Ascent Group reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
Ascent Group sold 341 Chemed shares in Q2 2025, an estimated $210K.
Ascent Group first reported a position in Chemed in Q4 2024 and held it in 2 quarters.
Ascent Group's Chemed position peaked at $258K in Q4 2024.
537 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on Ascent Group's 13F filing for Q2 2025, filed 21 Jul 2025.